Published in Mol Endocrinol on April 01, 1993
Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res (2001) 4.23
The human glucocorticoid receptor: molecular basis of biologic function. Steroids (2009) 1.69
Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids. Cell Stress Chaperones (2004) 1.62
Feed-forward inhibition of androgen receptor activity by glucocorticoid action in human adipocytes. Chem Biol (2012) 1.47
Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements. Mol Endocrinol (2006) 1.26
Non-overlapping progesterone receptor cistromes contribute to cell-specific transcriptional outcomes. PLoS One (2012) 1.09
Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. PLoS One (2012) 0.99
DNA recognition by the aberrant retinoic acid receptors implicated in human acute promyelocytic leukemia. Cell Growth Differ (2001) 0.99
Differential modulation of glucocorticoid and progesterone receptor transactivation. Mol Cell Endocrinol (2007) 0.97
Progesterone receptors, their isoforms and progesterone regulated transcription. Mol Cell Endocrinol (2011) 0.92
Differential responses of progesterone receptor membrane component-1 (Pgrmc1) and the classical progesterone receptor (Pgr) to 17β-estradiol and progesterone in hippocampal subregions that support synaptic remodeling and neurogenesis. Endocrinology (2011) 0.89
ALU repeats in promoters are position-dependent co-response elements (coRE) that enhance or repress transcription by dimeric and monomeric progesterone receptors. Mol Endocrinol (2009) 0.88
Progesterone and HMOX-1 promote fetal growth by CD8+ T cell modulation. J Clin Invest (2015) 0.86
Glucocorticoid receptor: implications for rheumatic diseases. Clin Exp Rheumatol (2011) 0.83
Genetic variations within the ERE motif modulate plasticity and energetics of binding of DNA to the ERα nuclear receptor. Arch Biochem Biophys (2011) 0.79
In silico modelling of hormone response elements. BMC Bioinformatics (2006) 0.79
Cripto-1 Ablation Disrupts Alveolar Development in the Mouse Mammary Gland through a Progesterone Receptor-Mediated Pathway. Am J Pathol (2015) 0.77
Progesterone receptor activates Msx2 expression by downregulating TNAP/Akp2 and activating the Bmp pathway in EpH4 mouse mammary epithelial cells. PLoS One (2012) 0.76
Differential mouse-strain specific expression of Junctional Adhesion Molecule (JAM)-B in placental structures. Cell Adh Migr (2016) 0.75
Activation of Peroxisome Proliferator-activated Receptor γ (PPARγ) and CD36 Protein Expression: THE DUAL PATHOPHYSIOLOGICAL ROLES OF PROGESTERONE. J Biol Chem (2016) 0.75
Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell (2001) 2.44
High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol Cell Biol (1998) 2.38
A rapid, sensitive, and inexpensive assay for chloramphenicol acetyltransferase. DNA (1987) 2.24
A complete library of point substitution mutations in the glucocorticoid response element of mouse mammary tumor virus. Proc Natl Acad Sci U S A (1986) 2.21
The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. J Biol Chem (1998) 2.08
Monoclonal antibodies against three major glycoproteins of varicella-zoster virus. Infect Immun (1983) 1.95
The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol Cell Biol (2000) 1.83
Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J Biol Chem (1992) 1.70
The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences. Mol Cell Biol (1994) 1.65
Following anterior resection for rectal cancer, defunctioning ileostomy closure may be significantly delayed by adjuvant chemotherapy: a retrospective study. Colorectal Dis (2007) 1.54
Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer. Cancer Res (1986) 1.53
Varicella-zoster virus-specific gp140: a highly immunogenic and disulfide-linked structural glycoprotein. Virology (1984) 1.49
Regulated expression of vimentin cDNA in cells in the presence and absence of a preexisting vimentin filament network. J Cell Biol (1990) 1.44
Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody. Mol Endocrinol (2000) 1.39
The presence or absence of a vimentin-type intermediate filament network affects the shape of the nucleus in human SW-13 cells. J Cell Sci (1994) 1.36
The cyclin B2 component of MPF is a substrate for the c-mos(xe) proto-oncogene product. Cell (1990) 1.35
Human progesterone receptor complexed with the antagonist RU 486 binds to hormone response elements in a structurally altered form. Mol Endocrinol (1989) 1.29
Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo. Mol Endocrinol (1999) 1.23
Estrogen induced synthesis of specific proteins in human breast cancer cells. Biochem Biophys Res Commun (1980) 1.22
Phosphorylation of human progesterone receptor by cyclin-dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo. Mol Endocrinol (1997) 1.22
DNA intersegment transfer, how steroid receptors search for a target site. J Biol Chem (1997) 1.20
Ha-rasVal-12,Thr-59 activates S6 kinase and p34cdc2 kinase in Xenopus oocytes: evidence for c-mosxe-dependent and -independent pathways. Mol Cell Biol (1990) 1.19
The validation of new aromatase monoclonal antibodies for immunohistochemistry--a correlation with biochemical activities in 46 cases of breast cancer. J Steroid Biochem Mol Biol (2005) 1.18
Estrogen and progesterone receptor proteins in breast cancer. Biochim Biophys Acta (1979) 1.16
Estrogen regulation of specific messinger RNA's in human breast cancer cells. Biochem Biophys Res Commun (1980) 1.16
Coregulatory proteins in steroid hormone receptor action: the role of chromatin high mobility group proteins HMG-1 and -2. Steroids (1999) 1.15
Immunologic analysis of human breast cancer progesterone receptors. 1. Immunoaffinity purification of transformed receptors and production of monoclonal antibodies. Biochemistry (1987) 1.13
Identification of a phosphorylation site in the hinge region of the human progesterone receptor and additional amino-terminal phosphorylation sites. J Biol Chem (2000) 1.13
Dimerization of mammalian progesterone receptors occurs in the absence of DNA and is related to the release of the 90-kDa heat shock protein. Proc Natl Acad Sci U S A (1991) 1.13
Distribution of an estrogen-induced protein with a molecular weight of 24,000 in normal and malignant human tissues and cells. Cancer Res (1983) 1.13
Ligands induce conformational changes in the carboxyl-terminus of progesterone receptors which are detected by a site-directed antipeptide monoclonal antibody. Mol Endocrinol (1992) 1.11
Rapid changes in initiation-limited rates of protein synthesis in rat thymic lymphocytes correlate with energy charge. Biochem Biophys Res Commun (1977) 1.11
A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 (steroid receptor coactivator 1) Mol Endocrinol (1999) 1.10
A quantitative comparison of dual control of a hormone response element by progestins and glucocorticoids in the same cell line. Mol Endocrinol (1989) 1.09
The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways. Proc Natl Acad Sci U S A (1993) 1.08
Glucocorticoid action on rat thymic lymphocytes. Experiments utilizing adenosine to support cellular metabolism lead to a reassessment of catabolic hormone actions. J Biol Chem (1976) 1.07
Improving exposure and safety at the saphenofemoral junction. Ann R Coll Surg Engl (1995) 1.07
Gastrointestinal haemorrhage after abdominal aortic grafting. J R Soc Med (1999) 1.06
The differential capacity of glucocorticoids and progestins to alter chromatin structure and induce gene expression in human breast cancer cells. Mol Endocrinol (1994) 1.05
Identification of a group of Ser-Pro motif hormone-inducible phosphorylation sites in the human progesterone receptor. Mol Endocrinol (1995) 1.04
A new rat gene RT7 is specifically expressed during spermatogenesis. Dev Biol (1990) 1.04
Latent agonist activity of the steroid antagonist, RU486, is unmasked in cells treated with activators of protein kinase A. Mol Endocrinol (1993) 1.04
A sequence in the 5' flanking region confers progestin responsiveness on the human c-myc gene. J Steroid Biochem Mol Biol (1997) 1.02
Steroid hormone-dependent interaction of human progesterone receptor with its target enhancer element. Mol Endocrinol (1988) 1.01
Monoclonal antibody storage conditions, and concentration effects on immunohistochemical specificity. J Histochem Cytochem (1983) 1.01
Detection of a Mr 24,000 estrogen-regulated protein in human breast cancer by monoclonal antibodies. Cancer Res (1983) 1.00
Human progesterone receptor binding to mouse mammary tumor virus deoxyribonucleic acid: dependence on hormone and nonreceptor nuclear factor(s). Mol Endocrinol (1989) 1.00
Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor. Mol Endocrinol (2000) 0.99
The 5'-flanking region of the ovine follicle-stimulating hormone-beta gene contains six progesterone response elements: three proximal elements are sufficient to increase transcription in the presence of progesterone. Endocrinology (1995) 0.99
Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors. Mol Endocrinol (1992) 0.99
Human sperm plasma membrane progesterone receptor(s) and the acrosome reaction. Biol Reprod (1996) 0.99
Interaction of the progesterone receptor with binding proteins for FK506 and cyclosporin A. Mol Endocrinol (1995) 0.99
Rectovaginal fistula in Crohn's disease. Dis Colon Rectum (2007) 0.99
Identification of phosphorylation sites unique to the B form of human progesterone receptor. In vitro phosphorylation by casein kinase II. J Biol Chem (1994) 0.97
The high mobility group protein 1 enhances binding of the estrogen receptor DNA binding domain to the estrogen response element. Mol Endocrinol (1998) 0.97
Phosphorylation and progesterone receptor function. J Steroid Biochem Mol Biol (1995) 0.97
Characterization and functional properties of the A and B forms of human progesterone receptors synthesized in a baculovirus system. Mol Endocrinol (1991) 0.96
Progesterone regulates proliferation of endothelial cells. J Biol Chem (1999) 0.96
17 alpha-Estradiol is a biologically active estrogen in human breast cancer cells in tissue culture. Endocrinology (1980) 0.94
Estradiol stimulates synthesis of a major intracellular protein in a human breast cancer cell line (MCF-7). Breast Cancer Res Treat (1981) 0.94
Endotoxin induces cardiac HSP70 and resistance to endotoxemic myocardial depression in rats. Am J Physiol (1996) 0.94
Visualizing protein-protein interactions in the nucleus of the living cell. Mol Endocrinol (1999) 0.93
Validation of new aromatase monoclonal antibodies for immunohistochemistry: progress report. J Steroid Biochem Mol Biol (2003) 0.93
The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation. Endocrinology (1998) 0.91
Structural analysis of chicken oviduct progesterone receptor using monoclonal antibodies to the subunit B protein. Biochemistry (1984) 0.90
Conditional modulation of glucocorticoid receptor activities by CREB-binding protein (CBP) and p300. J Steroid Biochem Mol Biol (1999) 0.90
Management of the rectal stump after emergency sub-total colectomy: which surgical option is associated with the lowest morbidity? Colorectal Dis (2005) 0.90
Modulation of cell signaling pathways can enhance or impair glucocorticoid-induced gene expression without altering the state of receptor phosphorylation. J Biol Chem (1993) 0.89
Small fragment wounds: biophysics, pathophysiology and principles of management. J R Army Med Corps (2001) 0.89
Hinge and amino-terminal sequences contribute to solution dimerization of human progesterone receptor. Mol Endocrinol (1997) 0.89
Transcriptional analysis of chromatin assembled with purified ACF and dNAP1 reveals that acetyl-CoA is required for preinitiation complex assembly. J Biol Chem (2000) 0.89
Progesterone receptor-induced bending of its target DNA: distinct effects of the A and B receptor forms. Mol Endocrinol (1996) 0.89
Immunologic analysis of human breast cancer progesterone receptors. 2. Structure, phosphorylation, and processing. Biochemistry (1987) 0.88
Two types of anti-progestins have distinct effects on site-specific phosphorylation of human progesterone receptor. J Biol Chem (1996) 0.88
The coupling of multiple signal transduction pathways with steroid response mechanisms. Endocrinology (1994) 0.88
Analysis of steroid hormone-induced histone acetylation by chromatin immunoprecipitation assay. Methods Mol Biol (2001) 0.88
Immunohistochemical detection of an estrogen-regulated protein by monoclonal antibodies. Cancer Res (1982) 0.87
Steroid-selective initiation of chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter is controlled by the site of promoter integration. J Biol Chem (1998) 0.87
Human progesterone A-receptors can be synthesized intracellularly and are biologically functional. Biochem Biophys Res Commun (1988) 0.87
Separation of effects of adenosine on energy metabolism from those on cyclic AMP in rat thymic lymphocytes. J Biol Chem (1977) 0.87
Stoichiometry and site-specific phosphorylation of human progesterone receptor in native target cells and in the baculovirus expression system. J Biol Chem (1996) 0.87
Nuclear accessory factors enhance the binding of progesterone receptor to specific target DNA. J Steroid Biochem Mol Biol (1994) 0.87
Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay. Mol Endocrinol (1998) 0.87
Evaluations of wasted mouse fibroblasts and SV-40 transformed human fibroblasts as models of ataxia telangiectasia in vitro. Mutat Res (1984) 0.87
Antiprogestins mediate differential effects on glucocorticoid receptor remodeling of chromatin structure. J Biol Chem (1998) 0.86
Photoaffinity labeling of glucocorticoid receptors. J Biol Chem (1981) 0.86
16 alpha-substituted analogs of the antiprogestin RU486 induce a unique conformation in the human progesterone receptor resulting in mixed agonist activity. Proc Natl Acad Sci U S A (1996) 0.86
Modulators of cellular protein phosphorylation alter the trans-activation function of human progesterone receptor and the biological activity of progesterone antagonists. Breast Cancer Res Treat (1993) 0.85
Expression and purification of recombinant human progesterone receptor in baculovirus and bacterial systems. Methods Mol Biol (2001) 0.84
Molecular cloning of a cDNA for the chicken progesterone receptor B antigen. Proc Natl Acad Sci U S A (1984) 0.84
Effects of fasting and insulin administration on polyribosome formation in rat epididymal fat cells. J Biol Chem (1980) 0.84
Evidence that heat shock protein-70 associated with progesterone receptors is not involved in receptor-DNA binding. Mol Endocrinol (1991) 0.84
A 361 base pair region of the rat FSH-beta promoter contains multiple progesterone receptor-binding sequences and confers progesterone responsiveness. Mol Cell Endocrinol (1997) 0.84